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Behcet's Syndrome: Case Report and Literature Review 
K. v. Venkatasubramaniam, MD* and Douglas R. Swinehart, MD** 
Behcet's syndrome is a disease commonly found in japan 
and in countries around the Mediterranean Sea. In the U.S., 
it is relatively uncommon. This report describes a 24-year-
old Lebanese-American man with Behcet's syndrome who 
presented with symptoms four months after he developed 
arthritis and who had been initially diagnosed as having 
incomplete Reiter's syndrome. A literature review is 
Included. 
In 1937, a Turkish dermatologist, Hulusi Behcet, described 
a triple syndrome consisting of recurrent, painful oral and 
genital ulcers and recurrent ulcers of the eye. His original 
description was based upon an examination of three pa-
tients (1). The syndrome is now recognized as a multi-
systemic disorder with mucocutaneous, ocular, intestinal, 
articular, vascular, urogenital, and neurological involve-
ment (2,3), and it is classified with other mucocutaneous-
ocular syndromes, e.g., erythema multiforme and Reiter's 
syndrome (4). The etiology remains unknown. No specific 
diagnostic or therapeutic aid is known. The disease is 
common in Japan and in the countries surrounding the 
Mediterranean Sea, such as Turkey, Italy, Greece, Israel, 
Lebanon, and other Arab lands. A few patients with this 
syndrome have been diagnosed recently in England and 
Germany. However, Behcet's syndrome is still an uncom-
mon disease in the U.S. (5). This paper includes a report on 
a Lebanese-American patient with Behcet's syndrome and 
a complete literature review. 
Epidemiology 
In Japan, the number of patients with Behcet's syndrome 
has increased dramatically since World War II. In 1972-73, 
a nationwide survey yielded an estimated 7000-8500 pa-
Submitted for publication: March 31, 1981 
Accepted for publication: April 22, 1981 
* Division of Rheumatology, Department of Internal Medicine, Henry 
Ford Hospital 
** Former Resident, Department of Dermatology, Henry Ford Hospital 
Address reprint requests to Dr. Venkatasubramaniam, Division of Rheu-
matology, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, Ml 48202 
tients, for a prevalence rate of 0.67:1,000 persons (6,7). 
More patients were found in the colder, northern parts of 
Japan (6,7). This prevalence rate is about ten times greater 
than that of northern England, where a survey done at 
Yorkshire found 32 patients in a population of five million 
(8). In the U.S., the prevalence rate for Olmstead County, 
Minnesota was 1:300,000 persons (9). Current estimates in 
Japan place the number of patients wfth Behcet's syndrome 
at 11,000 (9). Interestingly, while the syndrome has been 
found in Hawaii, none of the diagnosed patients were 
Japanese or Japanese-Americans, despite the frequency of 
the disease in Japan and the large Japanese population in 
Hawaii (10,11). 
Historical Background 
The earliest description of Behcet's syndrome as an acute 
endemic disease can be found in the writings of Hippocr-
ates (12). Shigeta (1924), Adamantiadis (1931), and White-
well (1934) described cases similar to Behcet's syndrome 
which preceded Behcet's classic paper in 1937 (1,13-15), 
from which the presently accepted name derives. Some 
have used the terms complete, abortive, partial, or in-
complete to describe the clinical pattems of Behcet's syn-
drome (9), and Lehner has suggested dividing it into two 
major categories, the mucocutaneous or benign type and 
the neuro-ocular type, which may have more serious con-
sequences (16). 
Diagnostic Criteria 
The Behcet's Disease Research Committee of Japan (1972) 
developed diagnostic criteria (Table 1) which are more 
useful for classification than forclinical discrimination (17). 
The Committee proposed four major criteria for the diag-
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Major Criteria 
TABLE I 
Diagnosis of Behcet's Syndrome 
Minor Criteria 
1. Mouth (apththous) 
Ulcers 
2. Iritis (with hypopyon) 
3. Genital Ulcers 
Skin Lesions 
a. pyoderma 
b. nodose lesions 
1. Arthritis 
a. of major joints 
b. arthralgias 
2. Vascular Disease 
a. migratory superficial phlebitis 
b. major vessel thrombosis 
c. aneurysms 
d. peripheral gangrene 
e. retinal and vitreous 
hemorrhage, papilledema 
3. Central Nervous System Disease 
a. brain stem syndrome 
b. meningomyelitis 
c. confusional states 
4. Gastronintestinal Disease 
a. malabsorption 
b. colonic ulcers 
c. dilated intestinal loops 
5. Epididymitis 
nosis of the complete syndrome, whereas articular, gas-
trointestinal, vascular, and nervous system involvement are 
considered minor criteria because they are less frequent 
(Table I). More recently, epididymitis and symptoms related 
to other organ systems have also been added to this classi-
fication. The incomplete syndrome requires that three ma-
jor criteria be present some of the time, that recurrent 
hypopyon, iritis, or retinitis occur, accompanied by one of 
the major criteria, or that at least one of two major criteria 
with some minor criterion be present with clinical suspi-
cion of the disease. It is important to realize that the 
complete type is not necessarily more severe than the 
incomplete (17). 
Case Report 
A 24-year-old native American-born Lebanese man experi-
enced recurrent painful oral ulcerations for two years. 
About four months before his first visit to Henry Ford 
Hospital, he noted left knee pain with swelling and subse-
quently developed pain in the right knee, ankles, feet, 
elbows, and low back. An incorrect diagnosis of Reiter's 
syndrome was made. Although the mucocutaneous lesions 
were painfu l , the patient improved on 100 mg Indo-
methacin daily. He was referred to the Rheumatology 
Clinic of Henry Ford Hospital in August 1978 because he 
had arthralgia and painful skin ulcerations on the shaft of 
the penis and scrotum that had been unresponsive to 
neosporin ointment, parenteral penicill in, and smallpox 
vaccine. His medical history revealed that he had had a 
bleeding duodenal ulcer four years earlier. 
Examination revealed a thin man with normal vital signs 
who was in acute discomfort. On his face was a deep ulcer 
w i th an erythematous halo on the left cheek, a few 
erythematous macules on the palate, and a white pustule 
on an erythematous base on the lower lip (Fig. 1). There 
were nontender anterior cervical and inguinal lymph nodes 
bilaterally. A trace of effusion was noted in the left knee 
with good range of motion of all joints. Multiple painful 
ulcerations were present on the penis and scrotum with no 
evidence of balanitis (Fig. 2). His physical examination was 
otherwise normal. 
Laboratory studies revealed a hemoglobin of 11 gms %, a 
mean corpuscular volume (MCV) of 80, total ironbinding 
capacity (TIBC) 276, and a serum iron of 60. The 
erythrocyte sedimentation rate (ESR) (Westergren) was 70 
mm per hour. The reticulocyte count was 1.3%, rheu-
matoid factor negative, VDRL test nonreactive, and the 
HLA-B27was posi t ive. Urinalysis, serum mult iphase 
screen, and chest x-ray were normal. The upper gastroin-
testinal x-rays revealed only a spastic duodenal bulb. X-
rays of the knee, lumbosacral spine, and pelvis were 
normal, as was an ophthalmologic examination. 
Fig. 1 
Ulcers on the palate suggest Behcet's syndrome. 
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Skin ulcerations in the peno-scrotal region. 
Because we suspected Behcet's syndrome, the patient was 
hospitalized for further tests. A biopsy from an ulceration of 
the scrotum revealed that the central portion of the epider-
mis was completely eroded and the margins were acantho-
tic. A dense inflammatory infiltrate throughout the dermis 
was composed of leukocytes, lymphocytes, plasma cells, 
and histiocytes (Fig. 3). Numerous scattered dilated vessels 
were seen in the upper dermis. Some vessels in the mid-
dermis showed endothelial cell proliferation and an invas-
ion by mononuclear cells. Many vessels were completely 
occluded. These changes were consistent with the ulcers of 
Behcet's syndrome. Domeboro compresses were applied 
to the open lesions along with Lidex in orabase ointment 
four times a day. Indocin (100 mg daily) was continued. The 
ulcers completely healed in six days. 
Etiopathogenesis 
The etiopathogenesis of Behcet's syndrome is complex and 
intriguing. The cause is still obscure, but a sequence of 
immunologic events has been implicated, perhaps precipi-
tated by genetic, viral, toxic, and allergic factors. 
1 
'mi^myy> 
Fig. 3 
Penile skin biopsy showing an inflammatory cellular infiltration of 
mononuclear cells located between the collagen bundles and in close 
apposition to the blood vessels (H & E 150 X). 
Metereologic factors have also been claimed as a cause, 
based chiefly on evidence suggesting its greater prevalence 
in colder climates and the greater frequency of attacks in 
Japan during the windy season. Hereditary factors are also 
implicated. The association between the HLA-B5 antigen 
and Behcet's syndrome is particularly strong in Japan and 
Turkey, the two countries of greatest prevalence. HLA-A2 
and HLA-B27 but not B5 was increased in a series from 
Yorkshire (U.K.), whereas HLA-B27 was not present in a 
recent American study of Behcet's syndrome (5,8,9,18-21). 
One theory is that Behcet's syndrome is an autoimmune 
disorder, since a patient's autoreactive antibody against 
oral mucous membranes has been detected in serum. This 
belief has been supported by recent immunofluorescence 
studies demonstrating the deposition of IgM, IgG, and beta 
IA globulin in the vessel walls of patients with Behcet's 
syndrome. The elevated serum complement levels (Cl, C4, 
C2 and C3), raised serum IgG, IgM and IgD, proportionate 
increase of T lymphocytes and suppression of B lympho-
cytes in patients with Behcet's syndrome all lend further 
credibility to the immunologic theory. The report of a 
macrophage migration inhibitory factor in the anterior 
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chamber of the eye in Behcet's syndrome suggests that cell-
mediated immunity might play a significant role (9). 
The immunologic and immunochemical findings in neu-
rological forms of Behcet's syndrome are important. De-
myelinating antibodies, similar to those found in multiple 
sclerosis, are detectable in more than 70% of patients with 
Behcet's syndrome and neurologic involvemenL While the 
antibodies in multiple sclerosis cause inhibition and de-
struction of the myelin, those in Behcet's syndrome do not 
appear to inhibit myelinization. Furthermore, an anti-
myelin serum factor (AMSE) has been reported recently in 
the serum and spinal fluid of patients with neuro-Behcet's 
syndrome during the acute and active phase. A less specific 
factor known as the cerebroside-binding serum factor 
(CBSF) has also been detected. The elevation of CSF-lgA, 
alpha-ll macroglobulin, and C3 in patients with neuro-
Behcet's syndrome is useful in assessing its severity. These 
findings seem to support the concept that an immunologic 
mechanism might play a significant role in the develop-
ment of the vascular and neurologic manifestations of 
Behcet's syndrome (7). 
The vascular lesions show fragmentation and splitting of 
the elastic fibers in the media and degeneration of the vasa 
vasorum associated with perivascular round cell infiltra-
tion, while those in the nervous system include the vascular 
changes described above as well as areas of diffuse de-
myel in ization and axonal degeneration. 
Clinical Features 
Aphthous ulcers 
Recurrent aphthous ulcers occur on the mucous mem-
branes of the lips, gingiva, cheeks (buccal mucosa), and 
tongue. The palate, tonsils, and pharynx are rarely in-
volved. Initially, a red, raised area appears that later be-
comes a shallow, round, or oval ulcer with erythematous 
borders. A white or yellowish pseudo-membrane generally 
covers the surface of this ulcer. Rarely, the ulcers may fuse 
to form a single large ulcer. Most aphthous ulcers heal 
without scarring except for those which fuse. In general, 
these ulcers tend to occur in crops and recur often (9,16). 
Skin lesions 
Erythema nodosum lesions may occur on the lower ex-
tremities and are less commonly seen on the face, neck, 
and buttocks. The lesion appears as an erythematous, 
elevated lesion, with subcutaneous induration and tender-
ness. They tend to recur but are generally self-limiting (2). 
Thrombophlebitis in the subcutaneous tissues is known to 
occur, especially in men, and commonly involves the 
subcutaneous venules of the extermities. Less commonly, 
migrating obi iterative thrombophlebitis has been known to 
occur (23). 
Acneiform skin eruptions resembling acne vulgaris appear 
frequently on the face, neck, breast, and back. Uncharac-
teristically, some lesions can become pustular, but pruritis 
is rare (23). 
Abnormal hyper-irritability o f the skin against nonspecific 
stimulation is found in 60-70% of patients who have 
Behcet's syndrome; however, it is not specific for the 
disorder (10,24,25). In areas where the syndrome is preva-
lent, a test that uses an aseptic needle to prick the skin can 
be extremely helpful in diagnosis. The patient wi l l develop 
a tuberculin-like reaction with erythema and swelling at 
the injection site 24-48 hours later; aseptic pustules wi l l 
develop later. The above reaction can be induced by 
injection of physiologic saline, the patient's saliva, or the 
aseptic extract of a genital ulcer. Although the mechanism 
ofthis phenomenon is not known, it is thought to be related 
to increased chemotaxis. 
Ocular lesions 
The most serious problem in Behcet's syndrome is ocular 
lesions, which involve recurrent episodes of anterior and 
posterior uveitis sometimes leading to lossof vision. Hypo-
pyon iritis, resulting from anterior uveitis, is atypical, often 
transient sign, lasting only a few days. Further ocular 
changes usually follow, with resultant recurrent posterior 
uveitis, bleeding and exudate formation in the choroid and 
retina. In a more advanced stage, loss of vision occurs 
secondary to optic atrophy, glaucoma, and cataract. Very 
rarely, phthisis bulbae might develop. It usually takes about 
five years from the onset of ocular symptoms for the patient 
to lose eyesight completely. Severe ocular involvement 
seems to be more characteristic of Japanese patients with 
Behcet's syndrome than of other nationalities (26). 
Genital lesions 
Aphthous ulcers similar to those in the mouth occur most 
frequently on the scrotum and vulva and less commonly on 
the penis, perianal and vaginal mucosa. Genital ulcers are 
deeper than the oral and may cause scarring. Because the 
genital lesions in men tend to be more painful, they are 
more apt to be discovered by the patient. Epididymitis, 
which is frequently recurrent, has been reported in 4.5-8% 
of male patients (9). 
Articular manifestations 
A little over 50% of patients with Behcet's syndrome wi l l 
develop articular symptoms. The joint involvement is fre-
quently recurrent, asymmetric, and characterized by pain. 
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redness, and swelling. The knee is the most frequently 
involved joint, while the ankle, elbow and wrist are less 
frequently affected. The arthritis is seldom destructive. In 
contrast to Reiter's syndrome, the sacroiliac joint is seldom 
involved in Behcet's syndrome. Only 0.5-1% of the Jap-
anese patients showed sacroiliac joint involvement. The 
rheumatoid factor is negative in almost all cases. Rare cases 
of erosive arthritis and osteonecrosis of the femur have 
been documented (23,27-30). 
Gastrointestinal and hepatic manifestations 
Gastrointestinal symptoms, which may occur in about 50% 
of patients, include vomiting, abdominal pain, flatulence, 
diarrhea, and constipation. Malabsorption and maldiges-
tion are common. Ulcerations have been known to occur 
in the terminal ileum and caecum and could lead to 
perforation and fissure formation. In general, ulcerative 
lesions tend to occur more frequently in Japanese patients 
and carry a poor prognosis. Congestive changes in the liver 
secondary to occlusion of the hepatic vein (Budd-Chiari 
syndrome) have also been identified (9,31,32). 
Cardiovascular manifestations 
Although cardiac involvement is rare, vascular involve-
ment is much more frequent, severe, and can sometimes be 
fatal. Four types of vascular lesions are recognized: venous 
occlusions, arterial occlusion, aneurysm, and varices. Vas-
cular symptoms were identified in 7.7% of Japanese pa-
tients with Behcet's syndrome during a 1972 nationwide 
survey. The leading cause of death in Behcet's syndrome in 
Japan was due to the rupture of a large artery aneurysm 
(7,11,33). Venous lesions are generally more common than 
arterial lesions. 
Occlusion of the subclavian artery frequently leads to 
pulseless disease. Aneurysms o f the renal artery may lead 
to hypertension, while peripheral arterial occlusion pro-
duces symptoms of intermittent c laud ica t ion . Cere-
brovascular complications secondary to arterial occlusion 
are well documented (33). Venous occlusions involving the 
superior or inferior vena cava are frequently observed. The 
Budd-Chiari syndrome has also been known to occur 
(34-36). 
Arteriography, venography, and thermography have been 
used to study the different patterns of vascular involvement 
(37). Generally, it occurs more often in men than in women 
and is less common when ocular signs are present or 
permanent (38). 
Central nervous system manifestations 
Nervous system involvement in Behcet's syndrome, which 
was first described in 1941, has been well defined and 
recognized in Japan. It is usually associated with a poor 
prognosis. Meningeal disease could mimic the features of 
microbial meningitis. Vascular occlusions could involve 
the cerebral or vertebrobasilar circulation, while par-
enchymatous involvement leading to brain stem, cerebel-
lar, and spinal long tract damage have also been well 
described. Psychological changes, characterized by am-
nesia, dementia and personality disturbances, are present 
in at least 50% of cases (39-42). 
Diagnosis and Treatment 
The diagnosis of this condition remains syndromic. In 
addition to the clinical findings, several nonspecific labora-
tory abnormalities support the diagnosis. These include the 
increase of serum mucoproteins, reduced albumin, in-
creased globulin, elevated erythrocyte sedimentation rate, 
increased serum concentrations of IgG, IgM and IgD, ele-
vated serum glycoproteins and sialic acid, leukocytosis, 
and positive tests for C-reaction protein. In addition, circu-
lating antibodies against human mucosal cells and lympho-
cytotoxicity to oral epithelial cells have also been found. 
Most of the abnormalities are detected during the acute 
attacks and diminish or disappear during remissions (9). 
The "needle reaction" is one of the most reliable methods 
for diagnosis but is unfortunately not present in all patients. 
Rosettes of platelets around granulocytes may be detecta-
ble during the acute phase or during acute attacks and may 
point to the diagnosis. However, this phenomenon is cal-
cium-dependent and thereby demonstrable only in edetic-
acid (EDTA) anticoagulated blood (24,25,43). 
Differential diagnosis 
The most important diseases which mimic some of the 
mucocutaneous clinical features of Behcet's syndrome in-
clude 1) Reiter's syndrome, 2) Stevens-Johnson syndrome, 
3) aphthous stomatitis, 4) syphilis, 5) erythema nodosum, 
and 6) herpetic stomatitis. The joint manifestations should 
be differentiated from those of Reiter's syndrome. 
Reiter's syndrome is characterized by a triad of urethritis, 
conjunctivitis, and arthritis, as well as by mucocutaneous 
lesions. The knee is also commonly affected, and the 
sacroiliac joint and thoracolumbar spine are invariably 
affected in longstanding cases. Behcet's syndrome is dif-
ferentiated from Reiter's syndrome by the painful oral and 
genital ulcerations, recurrent uveitis, and arthralgias rather 
than arthritis and vasculitis. The lack of sacroiliac joint 
involvement in Behcet's syndrome is an important point in 
differentiation. 
Clinical course 
In the typical case, oral aphthous ulcers appear first, fol-
lowed by skin lesions, ocular and genital involvement. In 
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most instances, nervous system and vascular compl ications 
occur later. In most patients frequent attacks occur early in 
the disease followed by a slowing of activity. Eye symptoms 
tend to become chronic and eventually lead to loss of 
visual acuity or to blindness. 
Men appear to be affected more often than women (ratio 
1.2 to 2). However, a female preponderance has been 
noted in a series reported from the U.S. and the U.K. In 
general, the younger the patient, the poorer the prognosis. 
Young men usually have the worst prognosis (8,42,44). The 
mucocutaneous lesions without ocular involvement are 
relatively frequent in women over 45; this has been termed 
the incomplete type of Behcet's syndrome. 
Prognostic predictors of Behcet's syndrome are not well 
delineated. In general, progression of neurologic disease 
carries a poor prognosis. Death generally results from 
lesions of the central nervous system or vascular system 
and from intestinal perforation (9). 
Management 
The treatment of Behcet's syndrome is controversial and 
difficult. Some aspects of therapy continue to be empirical 
and palliative. Transfer factor has been used in some 
studies and has had moderate-to-great effectiveness in 
controlling some recalcitrant lesions and in reducing the 
number of new lesions and new attacks. More recently, 
immunosuppressive therapy has been recommended, 
while immunostimulant drugs (e.g., Levamisole) have also 
been used. Colchicine has been used in some cases, chiefly 
because of its ant ichemotact ic activity. In the past, 
fibrinolytic drugs have also been used, chiefly to combat 
the fibrinolytic deficiency. Corticosteroids have largely 
been used as a palliative mode of therapy (9). 
Discussion 
In the U.S., Behcet's syndrome is still considered rather 
uncommon (5,28), although Duffy, et al (44) believe that 
the disease usually passes unrecognized and is not that 
rare. They described clinical and immunologic findings in 
10 patients with Behcet's syndrome. Other cases reported 
in the U.S. include that of a 49-year-old woman with 
uveitis, recurrent orogenital lesions, polyarthritis, and skin 
lesions (30); a patient with recurrent pneumonia associated 
with Behcet's syndrome that occurred over 13 years; a 
patient with thrombophlebitis, skin lesions, diffuse pul-
monary infiltrate, and severe hemoptysis (45); and a patient 
with Behcet's syndrome and neurologic involvement (22). 
Behcet's syndrome is a multisystemic disease. Our patient 
presented with recurrent aphthous and genital ulceration, 
two major criteria, and with arthritis that was neither 
episodic nor destructive. In the light of a high index of 
suspicion clinically, these criteria would justify the diag-
nosis of incomplete Behcet's syndrome, which was consist-
ent with the biopsy findings. His positive HLA-B27 antigen 
is interesting, although a clear relationship between this 
factor and Behcet's syndrome remains speculative. Our 
patient may eventually develop ocular or other manifesta-
tions characteristic ofthis syndrome. As yet, the patient has 
had no serious problems but eventually he might require 
the therapeutic agents mentioned. His prognosis therefore 
remains guarded. 
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